Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PZ5Q
|
|||
| Drug Name |
MK-5160
|
|||
| Indication | Type-1/2 diabetes [ICD-11: 5A10-5A11] | Phase 1 | [1] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03095651) Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.